Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Diab

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|May 7, 2026
Integration of spatial single-cell proteomics and spatial metabolomics reveals tumor microenvironment predictive of immunotherapy response in mucosal melanomaJun Wang, Priyadharsini Nagarajan, Sungnam Cho, et al.
Cancer Research|May 3, 2006
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen, Adi Diab, Miguel-Angel Perales, et al.
Oncoimmunology|March 1, 2021
Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritisJamie S Lin, Omar Mamlouk, Umut Selamet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2020
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II StudyMeredith S Pelster, Stephen K Gruschkus, Roland Bassett, et al.
Cancer Medicine|March 9, 2021
The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanomaDai Ogata, Lauren E Haydu, Isabella C Glitza, et al.
Cancers|June 22, 2023
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative StudyMaria A Lopez-Olivo, Gabrielle F Duhon, Juan I Ruiz, et al.
Journal for Immunotherapy of Cancer|June 26, 2019
Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureNoha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.
Journal of Cutaneous Pathology|July 19, 2018
Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumorKrishna Arudra, Ravi Patel, Michael T Tetzlaff, et al.
Melanoma Research|December 3, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literatureJane Mattei, Lin Ruitao, Michael A Davies, et al.
Journal for Immunotherapy of Cancer|April 18, 2019
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureNoha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|May 7, 2026
Integration of spatial single-cell proteomics and spatial metabolomics reveals tumor microenvironment predictive of immunotherapy response in mucosal melanomaJun Wang, Priyadharsini Nagarajan, Sungnam Cho, et al.
Cancer Research|May 3, 2006
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen, Adi Diab, Miguel-Angel Perales, et al.
Oncoimmunology|March 1, 2021
Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritisJamie S Lin, Omar Mamlouk, Umut Selamet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2020
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II StudyMeredith S Pelster, Stephen K Gruschkus, Roland Bassett, et al.
Cancer Medicine|March 9, 2021
The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanomaDai Ogata, Lauren E Haydu, Isabella C Glitza, et al.
Cancers|June 22, 2023
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative StudyMaria A Lopez-Olivo, Gabrielle F Duhon, Juan I Ruiz, et al.
Journal for Immunotherapy of Cancer|June 26, 2019
Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureNoha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.
Journal of Cutaneous Pathology|July 19, 2018
Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumorKrishna Arudra, Ravi Patel, Michael T Tetzlaff, et al.
Melanoma Research|December 3, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literatureJane Mattei, Lin Ruitao, Michael A Davies, et al.
Journal for Immunotherapy of Cancer|April 18, 2019
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureNoha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.
Pageof 14